Target CTA and the works-in-progress Adaptive Iterative Dose Reduction (AIDR) technology, by Toshiba, lower radiation dose and make CT imaging safer for patients.
Target CTA is a dose cardiac protocol for the Aquilion ONE that is designed for patients with stable heart rates, including pediatrics. When used with the company’s SURECardio Prospective, which can reduce radiation dose by up to 80 percent, Target CTA can lower radiation by another 20 percent.
AIDR is software that iterates noise out of the image to increase quality and lower radiation dose by up to 75 percent. The software intuitively improves the image by removing noise until the optimal image is produced. AIDR is pending 510(k) clearance and will come standard on the Aquilion Premium and Aquilion ONE.
For more information: www.medical.toshiba.com
August 14, 2026 
